-
2
-
-
0017715086
-
Evaluation of effects of interferon and interferon inducers on the immune response
-
Johnson, H.M., Baron, S. Evaluation of effects of interferon and interferon inducers on the immune response. Pharmac. Ther. 1977; 1: 349-367.
-
(1977)
Pharmac. Ther.
, vol.1
, pp. 349-367
-
-
Johnson, H.M.1
Baron, S.2
-
3
-
-
0343743081
-
The regulatory role of interferons in the human immune response
-
Taylor-Papadimitriou (Eds), Oxford Medical Publications
-
Balkwill, F. R. The regulatory role of interferons in the human immune response. In: Interferons: The impact in biology of medicine, Taylor-Papadimitriou (Eds), Oxford Medical Publications, 1985; 61-80.
-
(1985)
Interferons: The Impact in Biology of Medicine
, pp. 61-80
-
-
Balkwill, F.R.1
-
4
-
-
2542643691
-
Intrathecal administration of interferon in MS patients?
-
Karcher, D., Lowenthal, A. Strosberg, A. D. (Eds), Plenum, New York
-
Ververken, D., Carton, H., Biliau, A. Intrathecal administration of interferon in MS patients? In: Humoral immunity in neurological disease, Karcher, D., Lowenthal, A. Strosberg, A. D. (Eds), Plenum, New York, 1979; 625-627.
-
(1979)
Humoral Immunity in Neurological Disease
, pp. 625-627
-
-
Ververken, D.1
Carton, H.2
Biliau, A.3
-
5
-
-
2542587547
-
Interferon treatment of multiple sclerosis patients: A pilot study
-
Boese, A. (Ed.), Verlag Chemie, Weinheim
-
Fog, T. Interferon treatment of multiple sclerosis patients: a pilot study. In: Search for a cause of multiple sclerosis and other chronic diseases of the CNS, Boese, A. (Ed.), Verlag Chemie, Weinheim, 1980; 491-493.
-
(1980)
Search for a Cause of Multiple Sclerosis and Other Chronic Diseases of the CNS
, pp. 491-493
-
-
Fog, T.1
-
6
-
-
0005850941
-
A treatment for the chronic disabilities of stable multiple sclerosis
-
Montezuma-de-Carvalho, M. J. A treatment for the chronic disabilities of stable multiple sclerosis. Acta Medicotechnica 1983; 31: 155-160.
-
(1983)
Acta Medicotechnica
, vol.31
, pp. 155-160
-
-
Montezuma-de-Carvalho, M.J.1
-
7
-
-
0022339098
-
Serial immunological studies in multiple sclerosis patients treated systemically with human interferon alpha
-
Panitch, H. S., Francis, G. S., Hooper, C. J. Merigan, T. C., Johnson, K. P. Serial immunological studies in multiple sclerosis patients treated systemically with human interferon alpha. Ann. Neurol. 1985; 18: 434-438.
-
(1985)
Ann. Neurol.
, vol.18
, pp. 434-438
-
-
Panitch, H.S.1
Francis, G.S.2
Hooper, C.J.3
Merigan, T.C.4
Johnson, K.P.5
-
8
-
-
0023191664
-
Systemic alpha-interferon in multiple sclerosis: Long term patient follow-up
-
Panitch, H. S. Systemic alpha-interferon in multiple sclerosis: Long term patient follow-up. Arch. Neurol. 1987; 44: 61-63.
-
(1987)
Arch. Neurol.
, vol.44
, pp. 61-63
-
-
Panitch, H.S.1
-
9
-
-
0023782903
-
Systemic interferon therapy of multiple sclerosis: The pros
-
Knobler, R. L. Systemic interferon therapy of multiple sclerosis: the pros. Neurology 1988; 38: 58-61.
-
(1988)
Neurology
, vol.38
, pp. 58-61
-
-
Knobler, R.L.1
-
10
-
-
0025238999
-
Systemic lymphoblastoid interferon therapy in chronic progressive multiple sclerosis. I. Clinical and MRI evaluation
-
Kastrukoff, L. F., Oger, J. J., Hashimoto, S. A., Sacks, S. L., Li, D. K., Palmer, M. R., Koopmans, R. A., Pethau, A. J., Berkowitz, J., Paty, D. W. Systemic lymphoblastoid interferon therapy in chronic progressive multiple sclerosis. I. Clinical and MRI evaluation. Neurology 1990; 40: 479-486.
-
(1990)
Neurology
, vol.40
, pp. 479-486
-
-
Kastrukoff, L.F.1
Oger, J.J.2
Hashimoto, S.A.3
Sacks, S.L.4
Li, D.K.5
Palmer, M.R.6
Koopmans, R.A.7
Pethau, A.J.8
Berkowitz, J.9
Paty, D.W.10
-
11
-
-
0027418515
-
Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double blind, placebo-controlled trial
-
IFNB Multiple Sclerosis Study Group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double blind, placebo-controlled trial. Neurology 1993; 43: 655-661.
-
(1993)
Neurology
, vol.43
, pp. 655-661
-
-
-
12
-
-
0027521002
-
Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double blind, placebo-controlled trial
-
Paty, D. W., Li, D. K. B., UBC MS/MRI Study Group and IFNB Multiple Sclerosis Study Group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double blind, placebo-controlled trial. Neurology 1993; 43: 662-667.
-
(1993)
Neurology
, vol.43
, pp. 662-667
-
-
Paty, D.W.1
Li, D.K.B.2
-
13
-
-
0011853097
-
Results of a Phase III trial of intramuscular recombinant beta interferon as treatment for multiple sclerosis
-
Jacobs, L, Cookfair, D., Rudick, R., Herndon, R., Salazar, A., Fisher, J., Granger, C., Simon, J., Goodkin, D., and the MS Collaborative Group. Results of a Phase III trial of intramuscular recombinant beta interferon as treatment for multiple sclerosis. Ann. Neural. 1994; 36(2): 259.
-
(1994)
Ann. Neural.
, vol.36
, Issue.2
, pp. 259
-
-
Jacobs, L.1
Cookfair, D.2
Rudick, R.3
Herndon, R.4
Salazar, A.5
Fisher, J.6
Granger, C.7
Simon, J.8
Goodkin, D.9
-
14
-
-
0029069256
-
Interferon-α may benefit steroid unresponsive chronic inflammatory demyelinating polyneuropathy
-
Sabatelli, M., Mignogna, T., Lippi, G., Milone, M., Di Lazarro, V., Tonali, P. Interferon-α may benefit steroid unresponsive chronic inflammatory demyelinating polyneuropathy. J. Neurol. Neurosurg. Psych. 1995; 58: 638-639.
-
(1995)
J. Neurol. Neurosurg. Psych.
, vol.58
, pp. 638-639
-
-
Sabatelli, M.1
Mignogna, T.2
Lippi, G.3
Milone, M.4
Di Lazarro, V.5
Tonali, P.6
-
15
-
-
0343524980
-
A randomized trial comparing alpha-interferon and intravenous immunoglobulin in polyneuropathy associated with IgM monoclonal gammopathy
-
Leger, J. M., Xavier, M., Chastang, C., Clavelou, P., Louboutin, J. P., Bouche, P., Brouet, J. C. and the IgM Associated Polyneuropathy Study Group. A randomized trial comparing alpha-interferon and intravenous immunoglobulin in polyneuropathy associated with IgM monoclonal gammopathy. Neurology 1996; 46: A280.
-
(1996)
Neurology
, vol.46
-
-
Leger, J.M.1
Xavier, M.2
Chastang, C.3
Clavelou, P.4
Louboutin, J.P.5
Bouche, P.6
Brouet, J.C.7
-
16
-
-
84907109913
-
Suppression of experimental allergic encephalomyelitis by interferon
-
Abreu, S. L. Suppression of experimental allergic encephalomyelitis by interferon. Immunol. Comm. 1982; 11: 1-7.
-
(1982)
Immunol. Comm.
, vol.11
, pp. 1-7
-
-
Abreu, S.L.1
-
17
-
-
0020546230
-
Inhibition of passive localized experimental allergic encephalomyelitis by interferon
-
Abreu, S. L., Tondreau, J., Levine, D., Sowinskli, R. Inhibition of passive localized experimental allergic encephalomyelitis by interferon. Int. Arch. Allergy Appl. Immunol. 1983; 72: 30-33.
-
(1983)
Int. Arch. Allergy Appl. Immunol.
, vol.72
, pp. 30-33
-
-
Abreu, S.L.1
Tondreau, J.2
Levine, D.3
Sowinskli, R.4
-
18
-
-
0015520747
-
Interferon administered orally: Protection of neonatal mice from lethal virus challenge
-
Schafer, T. W., Lieberman, M., Cohen, M., Came, P. Interferon administered orally: protection of neonatal mice from lethal virus challenge. Science 1972; 176: 1326-1327.
-
(1972)
Science
, vol.176
, pp. 1326-1327
-
-
Schafer, T.W.1
Lieberman, M.2
Cohen, M.3
Came, P.4
-
19
-
-
0023772551
-
Oral use of human alpha interferon in cats
-
Cummins, J. M., Thompkins, M. S., Olsen, R. G., Tompkins, W. A., Lewis, M. G. Oral use of human alpha interferon in cats. J. Biol. Response Modifiers 1988; 7: 513-523.
-
(1988)
J. Biol. Response Modifiers
, vol.7
, pp. 513-523
-
-
Cummins, J.M.1
Thompkins, M.S.2
Olsen, R.G.3
Tompkins, W.A.4
Lewis, M.G.5
-
20
-
-
0025011019
-
Low-dose oral administration of human interferon alpha can control the development of Theileria parva infection in cattle
-
Young, A. S., Maritim, A. C., Karuiki, D. P., Stagg, D. A., Wafula, J. M., Mutugi, J. J., Cummins, J. M., Richards, A. S., Burns, C. Low-dose oral administration of human interferon alpha can control the development of Theileria parva infection in cattle. J. Parasital. 1990; 101: 201-209.
-
(1990)
J. Parasital.
, vol.101
, pp. 201-209
-
-
Young, A.S.1
Maritim, A.C.2
Karuiki, D.P.3
Stagg, D.A.4
Wafula, J.M.5
Mutugi, J.J.6
Cummins, J.M.7
Richards, A.S.8
Burns, C.9
-
21
-
-
0343208054
-
Modulation of a natural virus defense system by low concentrations of interferons at mucosal surfaces
-
Stanton, G., Hughes, T., Heard, H., Georgiades, J., Whorton, E. Modulation of a natural virus defense system by low concentrations of interferons at mucosal surfaces. J. Inf. Res. 1990; 10(S-1): S99.
-
(1990)
J. Inf. Res.
, vol.10
, Issue.S-1
-
-
Stanton, G.1
Hughes, T.2
Heard, H.3
Georgiades, J.4
Whorton, E.5
-
22
-
-
0025669818
-
Treatment of rotavirus infection in neonate and weanling pigs using natural human interferon alpha
-
Lecce, J. G., Cummins, J. M., Richards, A. S. Treatment of rotavirus infection in neonate and weanling pigs using natural human interferon alpha. J. Mol. Biotherapy 1990; 2: 211-216.
-
(1990)
J. Mol. Biotherapy
, vol.2
, pp. 211-216
-
-
Lecce, J.G.1
Cummins, J.M.2
Richards, A.S.3
-
23
-
-
0028236020
-
Suppression of relapsing experimental allergic encephalomyelitis in SJL/J mouse by oral administration of type I interferons
-
Brod, S. A., Burns, D. H. Suppression of relapsing experimental allergic encephalomyelitis in SJL/J mouse by oral administration of type I interferons Neurology 1994; 44: 1144-1148.
-
(1994)
Neurology
, vol.44
, pp. 1144-1148
-
-
Brod, S.A.1
Burns, D.H.2
-
24
-
-
0028964995
-
Modification of acute experimental autoimmune encephalomyelitis in the Lewis rat by oral administration of Type Interferons
-
Brod, S. A., Scott, M., Burns, D. K., Phillips, J. T. Modification of acute experimental autoimmune encephalomyelitis in the Lewis rat by oral administration of Type Interferons. J. Int. Res. 1995; 15: 115-122.
-
(1995)
J. Int. Res.
, vol.15
, pp. 115-122
-
-
Brod, S.A.1
Scott, M.2
Burns, D.K.3
Phillips, J.T.4
-
25
-
-
0016362676
-
Isolation of myelin from the nerve tissue
-
Norton, W. T. Isolation of myelin from the nerve tissue. Methods Enzymol 1975; 31 (part A): 435.
-
(1975)
Methods Enzymol
, vol.31
, Issue.PART A
, pp. 435
-
-
Norton, W.T.1
-
27
-
-
0025052428
-
Induction of severeexperimental autoimmune neuritis with a synthetic peptide corresponding to the 53-78 amino acid sequence of the myelin P2 protein
-
Rostami, A., Gregorian, S. K., Brown, M. J., Pleasure, D.E. Induction of severeexperimental autoimmune neuritis with a synthetic peptide corresponding to the 53-78 amino acid sequence of the myelin P2 protein. J. Neuroimmunol. 1990; 30: 145-151.
-
(1990)
J. Neuroimmunol.
, vol.30
, pp. 145-151
-
-
Rostami, A.1
Gregorian, S.K.2
Brown, M.J.3
Pleasure, D.E.4
-
28
-
-
0027053288
-
Transient cellular expression of interferon-gamma in myelin-induced and T cell line-mediated experimental autoimmune neuritis
-
Schmidt, B., Stoll, G., Van der Meide, P., Jung, S., Hartung, H.P. Transient cellular expression of interferon-gamma in myelin-induced and T cell line-mediated experimental autoimmune neuritis. Brain 1992; 115: 1633-1646.
-
(1992)
Brain
, vol.115
, pp. 1633-1646
-
-
Schmidt, B.1
Stoll, G.2
Van Der Meide, P.3
Jung, S.4
Hartung, H.P.5
-
29
-
-
0028903315
-
Oral administration of human or murine interferon alpha suppresses relapses and prevents adoptive transfer in EAE
-
Brod, S. A., Khan, M., Kerman, R. H., Pappolla, M. Oral administration of human or murine interferon alpha suppresses relapses and prevents adoptive transfer in EAE. J. Neuroimmunol. 1995; 58: 61-69
-
(1995)
J. Neuroimmunol.
, vol.58
, pp. 61-69
-
-
Brod, S.A.1
Khan, M.2
Kerman, R.H.3
Pappolla, M.4
-
30
-
-
0020646923
-
Immunosuppression caused by antigen feeding. II. Suppressor T cells mask Peyer's patches B cell priming to orally administered antigen
-
Macdonald, T. T. Immunosuppression caused by antigen feeding. II. Suppressor T cells mask Peyer's patches B cell priming to orally administered antigen. Eur. J. Immunol. 1983; 13: 138-142.
-
(1983)
Eur. J. Immunol.
, vol.13
, pp. 138-142
-
-
Macdonald, T.T.1
-
31
-
-
0343339583
-
Immunologic suppression after oral administration of antigen
-
Mattingly, J. A. Immunologic suppression after oral administration of antigen. Cell. Immunol. 1984; 86: 45-52.
-
(1984)
Cell. Immunol.
, vol.86
, pp. 45-52
-
-
Mattingly, J.A.1
-
32
-
-
0342542620
-
Oral tolerance to MBP induces TGF-β secreting T cells in Peyer's patch
-
Santes, L. M. B., Al-Sabbagh, A., Londono, A., Weiner, H. L. Oral tolerance to MBP induces TGF-β secreting T cells in Peyer's patch. J. Immunol. 1993; 150: 115A.
-
(1993)
J. Immunol.
, vol.150
-
-
Santes, L.M.B.1
Al-Sabbagh, A.2
Londono, A.3
Weiner, H.L.4
-
33
-
-
0020294048
-
Activation of a suppressor T cell pathway by interferon
-
Aune, T. M., Pierce, C. W. Activation of a suppressor T cell pathway by interferon. Proc. Natl. Acad. Sci. USA 1982; 79: 3808-3812.
-
(1982)
Proc. Natl. Acad. Sci. USA
, vol.79
, pp. 3808-3812
-
-
Aune, T.M.1
Pierce, C.W.2
-
34
-
-
0021340778
-
Identification and initial characterization of Con A and interferon-induced human suppressor factor: Evidence for a human equivalent of murine soluble immune response suppressor (SIRS)
-
Schnapper, H. W., Pierce, C. W., Aune, T. M. Identification and initial characterization of Con A and interferon-induced human suppressor factor: Evidence for a human equivalent of murine soluble immune response suppressor (SIRS). J. Immmunol. 1984; 132: 2429-2435.
-
(1984)
J. Immmunol.
, vol.132
, pp. 2429-2435
-
-
Schnapper, H.W.1
Pierce, C.W.2
Aune, T.M.3
-
35
-
-
0026601932
-
Inflammatory leukocyes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice
-
Merrill, J. E., Kono, D. H., Clayton, J., Ando, D. G., Hinton, D. R. Inflammatory leukocyes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice. Prac. Natl. Acad. Sci. USA 1992; 89: 810-815.
-
(1992)
Prac. Natl. Acad. Sci. USA
, vol.89
, pp. 810-815
-
-
Merrill, J.E.1
Kono, D.H.2
Clayton, J.3
Ando, D.G.4
Hinton, D.R.5
-
36
-
-
0025275195
-
The role of interferon-gamma in the pathogenesis of experimental autoimmune disease of the nervous system
-
Hartung, H. P., Schafer, B., Van der Meide, P. H., Fierz, W., Heininger, K., Toyka, K. V. The role of interferon-gamma in the pathogenesis of experimental autoimmune disease of the nervous system. Ann. Neurol. 1990; 27: 247-257.
-
(1990)
Ann. Neurol.
, vol.27
, pp. 247-257
-
-
Hartung, H.P.1
Schafer, B.2
Van Der Meide, P.H.3
Fierz, W.4
Heininger, K.5
Toyka, K.V.6
-
37
-
-
0026083952
-
Interferon-γ inhibition suppresses experimental allergic neuritis: Modulation of major histocompatibility complex expression on Schwann cells in vitro
-
Tsai, C. P., Pollard, J. O., Armati, P. J. Interferon-γ inhibition suppresses experimental allergic neuritis: modulation of major histocompatibility complex expression on Schwann cells in vitro. J. Neuroimmunol. 1991; 31: 133-145.
-
(1991)
J. Neuroimmunol.
, vol.31
, pp. 133-145
-
-
Tsai, C.P.1
Pollard, J.O.2
Armati, P.J.3
-
38
-
-
0025285859
-
Cytokines: Coordinators of immune and inflammtory responses
-
Arai, K., Lee, F., Miyajima, A., Miyatake, S., Arai, N., Yokata, T. Cytokines: Coordinators of immune and inflammtory responses. Annu. Rev. Biochem. 1990; 59: 783-836.
-
(1990)
Annu. Rev. Biochem.
, vol.59
, pp. 783-836
-
-
Arai, K.1
Lee, F.2
Miyajima, A.3
Miyatake, S.4
Arai, N.5
Yokata, T.6
|